vildagliptin and its Impurities
Vildagliptin is used in combination to treat Diabetes Mellitus Type 2. Vildagliptin is an oral anti-hyperglycemic agent. Reference standards of Vildagliptin API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
 
	
			                                  ![(2S,2'S)-1,1'-[[(3-Hydroxytricyclo[3.3.1.13,7]dec- PA 22 17540](https://www.pharmaffiliates.com/pimages/PA2217540.jpg) 
																				(2S,2'S)-1,1'-[[(3-Hydroxytricyclo[3.3.1.13,7]dec-1-yl)imino]bis(1-oxo-2,1-ethanediyl)]bis-2-pyrrolidinecarbonitrile
(2S,2'S)-1,1'-[[(3-Hydroxytricyclo[3.3.1.13,7]dec-1-yl)imino]bis(1-oxo-2,1-ethanediyl)]bis-2-pyrrolidinecarbonitrile
- Catalogue No.:PA 22 17540 
- CAS : - 1036959-23-5
- Molecular Formula : C24H33N5O3 
- Molecular Weight : 439.55 
 
	
			                                   
																				(S)-1-((E)-2-(((1r,3R,5R,7S)-3-Hydroxyadamantan-1-yl)imino)acetyl)pyrrolidine-2-carbonitrile
(S)-1-((E)-2-(((1r,3R,5R,7S)-3-Hydroxyadamantan-1-yl)imino)acetyl)pyrrolidine-2-carbonitrile
- Catalogue No.:PA 22 17600 
- CAS : - 1846606-31-2
- Molecular Formula : C17H23N3O2 
- Molecular Weight : 301.38 
 
	
			                                   
																				1-(5-((l2-Azanyl)carbonyl)-2,3-dihydro-1H-pyrrol-1-yl)-2-((3-hydroxyadamantan-1-yl)amino)ethan-1-one
1-(5-((l2-Azanyl)carbonyl)-2,3-dihydro-1H-pyrrol-1-yl)-2-((3-hydroxyadamantan-1-yl)amino)ethan-1-one
- Catalogue No.:PA 22 17630 
- CAS : - NA
- Molecular Formula : C17H24N3O3 
- Molecular Weight : 318.4 
 
	
			                                   
																				(S)-2-((1r,3R,5R,7S)-3-Hydroxyadamantan-1-yl)-1-iminohexahydropyrrolo[1,2-a]pyrazin-4(1H)-one
(S)-2-((1r,3R,5R,7S)-3-Hydroxyadamantan-1-yl)-1-iminohexahydropyrrolo[1,2-a]pyrazin-4(1H)-one
- Catalogue No.:PA 22 17800 
- CAS : - 1710765-32-4
- Molecular Formula : C17H25N3O2 
- Molecular Weight : 303.41 
 
	
			                                   
																				((1r,3R,5R,7S)-3-Hydroxyadamantan-1-yl)glycyl-L-proline compound with 2,2,2-Trifluoroacetic Acid (1:1)
((1r,3R,5R,7S)-3-Hydroxyadamantan-1-yl)glycyl-L-proline compound with 2,2,2-Trifluoroacetic Acid (1:1)
- Catalogue No.:PA 22 0171000 
- CAS : - 565453-41-0
- Molecular Formula : C19H27F3N2O6 
- Molecular Weight : 436.43 
 
	
			                                  ![(2S)-1-[2-[(3-Hydroxytricyclo[3.3.1.13,7]dec-1-yl) PA 22 0171019](https://www.pharmaffiliates.com/pimages/PA220171019.jpg) 
																				(2S)-1-[2-[(3-Hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]-2-pyrrolidine carboxylic acid lithium salt
(2S)-1-[2-[(3-Hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]-2-pyrrolidine carboxylic acid lithium salt
- Catalogue No.:PA 22 0171019 
- CAS : - NA
- Molecular Formula : C17H25LiN2O4 
- Molecular Weight : 328.34 
 
	
			                                   
																				2-((S)-1-(((1r,3R,5R,7S)-3-Hydroxyadamantan-1-yl)glycyl)pyrrolidin-2-yl)-4,5-dihydrothiazole-4-carboxylic Acid
2-((S)-1-(((1r,3R,5R,7S)-3-Hydroxyadamantan-1-yl)glycyl)pyrrolidin-2-yl)-4,5-dihydrothiazole-4-carboxylic Acid
- Catalogue No.:PA 22 0171026 
- CAS : - 2380224-94-0
- Molecular Formula : C20H29N3O4S 
- Molecular Weight : 407.53 
 
	
			                                   
																				(1R)-2-((2S)-2-Amino-2-((1r,5R,7S)-3-hydroxyadamantan-1-yl)acetyl)cyclopent-3-ene-1-carboxamide
(1R)-2-((2S)-2-Amino-2-((1r,5R,7S)-3-hydroxyadamantan-1-yl)acetyl)cyclopent-3-ene-1-carboxamide
- Catalogue No.:PA 22 0171028 
- CAS : - NA
- Molecular Formula : C18H26N2O3 
- Molecular Weight : 318.42 
 
	
			                                   
																				(2S,2'S)-1,1'-(2,2'-(Adamantane-1,3-diylbis(azanediyl))bis(acetyl))bis(pyrrolidine-2-carbonitrile)
(2S,2'S)-1,1'-(2,2'-(Adamantane-1,3-diylbis(azanediyl))bis(acetyl))bis(pyrrolidine-2-carbonitrile)
- Catalogue No.:PA 22 0171033 
- CAS : - 875314-89-9
- Molecular Formula : C24H34N6O2 
- Molecular Weight : 438.58 
 
	
			                                   
																				(2S)-1-((3-(2-((S)-2-Cyanopyrrolidin-1-yl)-2-oxoethoxy)adamantan-1-yl)glycyl)pyrrolidine-2-carbonitrile
(2S)-1-((3-(2-((S)-2-Cyanopyrrolidin-1-yl)-2-oxoethoxy)adamantan-1-yl)glycyl)pyrrolidine-2-carbonitrile
- Catalogue No.:PA 22 0171034 
- CAS : - NA
- Molecular Formula : C24H33N5O3 
- Molecular Weight : 439.56 
 
	
			                                   
																				2-(3-Hydroxyadamantan-1-yl)-1-iminohexahydropyrrolo[1,2-a]pyrazin-4(1H)-one Hydrochloride
2-(3-Hydroxyadamantan-1-yl)-1-iminohexahydropyrrolo[1,2-a]pyrazin-4(1H)-one Hydrochloride
- Catalogue No.:PA 22 0171035 
- CAS : - 2663700-61-4
- Molecular Formula : C17H26ClN3O2 
- Molecular Weight : 339.86 
 
	
			                                   
																				N-(2-((S)-2-Cyanopyrrolidin-1-yl)-2-oxoethyl)-N-((1R,3S,5R)-3-hydroxyadamantan-1-yl)nitrous amide
N-(2-((S)-2-Cyanopyrrolidin-1-yl)-2-oxoethyl)-N-((1R,3S,5R)-3-hydroxyadamantan-1-yl)nitrous amide
- Catalogue No.:PA 22 0171041 
- CAS : - NA
- Molecular Formula : C17H24N4O3 
- Molecular Weight : 332.4 

 
																				 
																				 
																				 
																				![N-(3-Hydroxytricyclo[3.3.1.13,7]dec-1-yl)glycyl-D- PA 22 17550](https://www.pharmaffiliates.com/pimages/PA2217550.jpg) 
																				![(R)-1-[2-(3-Hydroxyadamantan-1-ylamino)acetyl]pyrr PA 22 17560](https://www.pharmaffiliates.com/pimages/PA2217560.jpg) 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				![(8aS)-3-Hydroxyhexahydropyrrolo[1,2-a]pyrazine-1,4 PA 22 17700](https://www.pharmaffiliates.com/pimages/PA2217700.jpg) 
																				 
																				 
																				 
																				 
																				 
																				 
																				![N-(3-Hydroxytricyclo[3.3.1.13,7]dec-1-yl)glycyl-L- PA 22 17790](https://www.pharmaffiliates.com/pimages/PA2217790.jpg) 
																				 
																				 
																				 
																				![Octahydro-5H,10H-dipyrrolo[1,2-a:1',2'-d]pyrazine- PA 22 0171002](https://www.pharmaffiliates.com/pimages/PA220171002.jpg) 
																				![(R)-Tetrahydro-1H-pyrrolo[2,1-c][1,4]oxazine-1,4(3 PA 22 0171003](https://www.pharmaffiliates.com/pimages/PA220171003.jpg) 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				![3-Hydroxyhexahydropyrrolo[1,2-a]pyrazine-1,4-dione PA 22 0171044](https://www.pharmaffiliates.com/pimages/PA220171044.jpg) 
																				 
																				 
																				 
																				 
																				 
																				 
																				![1-[2-[(3-Hydroxy-1-adamantyl) amino] acetyl]pyrrol PA 22 0171051](https://www.pharmaffiliates.com/pimages/PA220171051.jpg) 
																				 
																				 
																				 
																				 
																				 
 
 
 
